DOVATO FDA approval date

The FDA approved DOVATO on 8 Apr 2019.

FDA approval date
8 Apr 2019

Drug identity has not yet been verified against registry records

Also recorded as DOLUTEGRAVIR SODIUM; LAMIVUDINE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-04-08DayDOVATOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211994", "applicant_as_listed_by_fda": "VIIV HLTHCARE", "brand_names": ["DOVATO"], "active_ingredients": ["DOLUTEGRAVIR SODIUM", "LAMIVUDINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190408", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026